Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uterine Neoplasms
×
trastuzumab deruxtecan
×
Clear all
Filters
2
NCT06989112
2026-03-12
DE-01
AstraZeneca
Phase 3
Recruiting
600 enrolled